T.C. MİNİSTRY OF HEALTH İZMİR PROVINCIAL HEALTH DIRECTORATE S.B.Ü. DR.BEHÇET UZ CHİLDREN'S EDUCATİON AND RESEARCH HOSPİTAL
T.C. MİNİSTRY OF HEALTH İZMİR PROVINCIAL HEALTH DIRECTORATE S.B.Ü. DR.BEHÇET UZ CHİLDREN'S EDUCATİON AND RESEARCH HOSPİTAL

Facebook Twitter Google Plus Linkedin

İlker Devrim, M.D.

Updated: 26/12/2018



Family Name, First Name:
Devrim İlker

Title: Professor of Pediatric Infectious Disease, MD, Born:  December 1975

Position and Affiliation

Chair,

Pediatric Infectious Diseases Department,Dr. BehçetUz Children's HospitalSaglikBilimleriUniversity, İzmir, Turkey.

Education

1993-1999 MD, Hacettepe University, School of Medicine, Ankara, Turkey

1999-2003 Pediatrics residency at Hacettepe University

2003-2007 Pediatric Infectious Disease fellowship at Hacettepe University

Professional Experience

2011-2017 Chief of the Pediatric Infectious Disease Department, Dr. BehçetUz Children's HospitalSaglikBilimleriUniversity, İzmir, Turkey.

2011-2017 President of the Infection Control Committee

2008-2011 Specialist at the Pediatric Infectious Disease Department, Dr. BehçetUz Children's Hospital

Memberships:

1.      ESCMID

2.      National Pediatric Association

Editorial Boards:

Scientific board of Mediterranean Journal of Hematology and Infectious Diseases

Associate editor of Journal of  Dr.BehcetUzChildrens Hospital

Publications: 90 scientific papers published in SCI and SCI-expanded indexed journals.

Research Interests:

Healthcare associated infections and prevention strategies.

Tuberculosis

Emerging antibiotic resistance in healthcare settings.

Antimicrobial and antifungal stewardship programs.

The economical impact of infections in children

Infections in immunocompromised children including pediatric hematology/oncology patients and BMT

Languages spoken: English and Turkish

Research papers(selected from 2018-2016):

·         Kulali F, Çalkavur Ş, Oruç Y, Demiray N, Devrim İ. Impact of central line bundle for prevention of umbilical catheter-related bloodstream infections in a neonatal intensive care unit: A pre-post intervention study.Am J Infect Control. 2018 Nov 27. pii: S0196-6553(18)30989-1. 

·         Devrim F, Serdaroğlu E, Çağlar İ, Oruç Y, Demiray N, Bayram N, Ağın H, Çalkavur S, Sorguç Y, Dinçel N, Ayhan Y, Yılmaz E, Devrim I.The Emerging Resistance in Nosocomial Urinary Tract Infections: From the Pediatrics Perspective.Mediterr J Hematol Infect Dis. 2018 Sep 1;10(1):e2018055.

·         Devrim İ, Oruç Y, Demirağ B, Kara A, Düzgöl M, Uslu S, Yaşar N, Aydın Köker S, Töret E, Bayram N, Vergin C.Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.J Vasc Access. 2018 Jul;19(4):358-365. doi: 10.1177/1129729818757955. Epub 2018 Mar 15.

·         Çağlar İ, Kafes C, Korcum M, Düzgöl M, Kara A, Bayram SN, Apa H, Devrim İ.IHospital Cost Analysis of Children with Preseptal Cellulitis” nt J PediatrOtorhinolaryngol. 2018 Mar;106:96-99

·         Alkan F, Gözmen S, Bayram N, Gülfidan G, Apa H, Ünal N, Devrim İ.Risk factors for bacteremia with extended-spectrum β-lactamase production in positive Escherichia coli bacteremia in a pediatric setting.Am J Infect Control. 2017 Dec 1;45(12):1414-1415.

·         Devrim İ, Yaşar N, İşgüder R, Ceylan G, Bayram N, Özdamar N, Turgut N, Oruç Y, Gülfidan G, Ağırbaş İ, Ağın H.Clinical impact and cost-effectiveness of a central line bundle including split-septum and single-use prefilled flushing devices on central line-associated bloodstream infection rates in a pediatric intensive care unit.Am J Infect Control. 2016 Aug 1;44(8):e125-8. doi: 10.1016/j.ajic.2016.01.038. Epub 2016 Apr 6.

·         Alkan F, Gözmen S, Bayram N, Gülfidan G, Apa H, Ünal N, Devrim İ.Risk factors for bacteremia with extended-spectrum β-lactamase production in positive Escherichia coli bacteremia in a pediatric setting.Am J Infect Control. 2017 Dec 1;45(12):1414-1415. doi: 10.1016/j.ajic.2017.08.023.

·         Devrim İ, İşgüder R, Ağın H, Ceylan G, Ayhan Y, Sandal ÖS, Sarı F, Kara A, Düzgöl M, Gülfidan G, Bayram N.Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.Mediterr J Hematol Infect Dis. 2016 Sep 1;8(1):e2016042. doi: 10.4084/MJHID.2016.042. eCollection 2016.

·         Devrim İ, Kara A, Düzgöl M, Karkıner A, Bayram N, Temir G, Şencan A, Sorguç Y, Gülfidan G, Hoşgör M. Burn-associated bloodstream infections in pediatric burn patients: Time distribution of etiologic agents. Burns. 2017 Feb;43(1):144-148. doi: 10.1016/j.burns.2016.07.030. Epub 2016 Sep 9

·         İşgüder R, Ceylan G, Ağın H, Gülfidan G, Ayhan Y, Devrim İ.New parameters for childhood ventilator associated pneumonia diagnosis.PediatrPulmonol. 2017 Jan;52(1):119-128. doi: 10.1002/ppul.23504. Epub 2016 Jun 9.

·         İşgüder R, Ağın H, Ceylan G, Bayram N, Devrim İ.Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit.Am J Infect Control. 2016 Jun 1;44(6):734-5. doi: 10.1016/j.ajic.2015.12.028. Epub 2016 Feb 23. No abstract available